ClinicalTrials.gov record
Recruiting Phase 2 Interventional

Evaluation of Efficacy and Safety of VX-993 for Pain Associated With Diabetic Peripheral Neuropathy

ClinicalTrials.gov ID: NCT06619860

Public ClinicalTrials.gov record NCT06619860. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Apr 22, 2026, 8:28 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Double-blind, Active-controlled, Dose-ranging, Parallel-design Study of the Efficacy and Safety of Oral VX-993 in Subjects With Pain Associated With Diabetic Peripheral Neuropathy

Study identification

NCT ID
NCT06619860
Recruitment status
Recruiting
Study type
Interventional
Phase
Phase 2
Lead sponsor
Vertex Pharmaceuticals Incorporated
Industry
Enrollment
300 participants

Conditions and interventions

Interventions

  • Placebo (matched to VX-993) Drug
  • Placebo (matched to pregabalin) Drug
  • Pregabalin Drug
  • VX-993 Drug

Drug

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Not listed

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Oct 17, 2024
Primary completion
Apr 29, 2026
Completion
May 29, 2026
Last update posted
Apr 20, 2026

2024 – 2026

United States locations

U.S. sites
25
U.S. states
15
U.S. cities
25
Facility City State ZIP Site status
Cullman Clinical Trials Cullman Alabama 35055 Completed
Trovare Clinical Research - Bakersfield CA Bakersfield California 93301 Completed
Eximia Research - San Diego La Mesa California 91942 Completed
Paradigm Clincial Research Centers, LLC., Wheat Ridge Wheat Ridge Colorado 80033 Completed
Accel Research - Deland DeLand Florida 32720 Completed
AMR Fort Myers (The Clinical Study Center) Fort Myers Florida 33912 Completed
Velocity Clinical Research - Hallandale Beach Hallandale Florida 33009 Completed
Health Awareness, Inc., Jupiter Jupiter Florida 33458 Completed
Suncoast Research Associates - Miami Miami Florida 33172 Completed
Innovation Medical Research Center - Palmetto Palmetto Bay Florida 33157 Completed
Health Awareness, Inc. - Port St. Lucie Port Saint Lucie Florida 34952 Completed
Atlanta Center for Medical Research Atlanta Georgia 30331 Completed
Accel Research - Decatur Decatur Georgia 30030 Completed
Velocity Clinical Research - Boise Meridian Idaho 83642 Completed
Healthcare Research Network - Flossmoor IL Flossmoor Illinois 604773027 Completed
Quest Research Institute Farmington Hills Michigan 48334 Completed
Healthcare Research Network - Hazelwood MO Hazelwood Missouri 63042 Completed
Eximia Research - Raleigh Raleigh North Carolina 27607 Completed
Velocity Clinical Research - Cleveland Beachwood Ohio 44122 Completed
Velocity Clinical Research - Providence East Greenwich Rhode Island 02818 Completed
Clinical Trials of South Carolina - Berkeley - Moncks Corner Moncks Corner South Carolina 29461 Completed
Gadolin Research Beaumont Texas 77702 Completed
Velocity Clinical Research, Dallas Dallas Texas 75230 Completed
San Antonio Clinical Trials San Antonio Texas 78240 Completed
AMR Norfolk Norfolk Virginia 23502 Completed

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 22 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT06619860, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Apr 20, 2026 · Synced Apr 22, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT06619860 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →